Business Wire

Earned, Owned and Social Media Analytics Leaders Partner To Help Companies Understand The Business Impact of Content

2.2.2021 19:54:00 EET | Business Wire | Press release

Share

Onclusive, the data science company for communications, and Shareablee, the social media analytics and competitive benchmarking company, today announced their strategic partnership to offer marketing and communications teams best-in-class solutions for earned, owned and social media insights. The partnership will help companies gain more holistic data about the performance of their owned and earned content across global news outlets, influencers and social media platforms.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210202005915/en/

Click to Tweet: Just announced: @Onclusive and @Shareablee partner to help companies measure the business impact of earned, owned, and social media marketing - through to revenue! https://bit.ly/39DF9xE #socialmediamarketing #prmeasurement

Social media, communications, public relations, and marketing teams each have a view of a company’s brand, reputation, and influence. Companies are increasingly looking to measure their owned and earned media strategies in a more centralized way by combining these functions within integrated teams and equipping them with comparable tools.

Particularly during times of crisis or uncertainty when companies put their emphasis on the tactics they can more closely control, social media amplification and paid media activation become even more important, as does measurement of the business impact of these efforts. The intersection between the data and solutions from Onclusive and Shareablee will provide organizations with more comprehensive content marketing data to better optimize their strategies.

Both Onclusive and Shareablee have their roots in enterprise media monitoring and content measurement and support Fortune 100 companies and their agencies. Both companies also recently launched mid-market products to deliver their data, platforms and services to a wider range of organizations.

“Social media strategies are fundamental to a company’s marketing plan, yet there is still more to the story. We are excited to be able to complete the picture for our clients via our relationship with Onclusive,” said Tania Yuki, CEO of Shareablee.

“We’ve always viewed our data and platforms as a bridge between communications teams and marketing teams. By working with Shareablee, our joint clients will be even better equipped to plan and execute harmonious cross-functional brand and communications strategies,” said Dan Beltramo, CEO of Onclusive.

About Onclusive

Onclusive is the data science company for communications. The inventors of PR Attribution™ and Power of Voice™, Onclusive measures the true impact that content is having on a company’s bottom line. The Onclusive platform is built upon a proprietary newscrawler which analyzes millions of earned, owned, and newswire articles every day globally and in over 100 languages, organizing each piece of content based on dozens of dimensions for aggregate and entity-level analysis.

The world’s leading brands and agencies including Airbnb, H&R Block, Lyft, Intercontinental Hotels Group, 23andMe, and Experian use Onclusive to modernize communications. For more information, visit onclusive.com and follow us on Twitter, LinkedIn, and Facebook.

About Shareablee

Shareablee is the leader in audience-based social media measurement for media publishers, agencies and brands that want to understand the impact and effectiveness of their cross-platform social media campaigns. Launched in 2013, Shareablee empowers brands by providing data that can help them define and drive success on social media by arming them with metrics and predictive analytics that inform powerful best practices. Shareablee is the leading authority on audience intelligence, competitive benchmarking and actionable insights with clients in 15+ countries.

For more information about Shareablee, visit shareablee.com and follow us on Twitter, LinkedIn, and Facebook.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Onclusive Contact:
Sean O'Neal
+1 415-906-5938
info@onclusive.com

Shareablee Contact:
Madison Busick
+1 508-868-4461
marketing@shareablee.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release

Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release

With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release

Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye